Literature DB >> 27490430

A second look: Efforts to repurpose old drugs against Zika cast a wide net.

Ellie Kincaid1.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27490430     DOI： 10.1038/nm0816-824

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  4 in total

1.  Chloroquine inhibits dengue virus type 2 replication in Vero cells but not in C6/36 cells.

Authors:  Kleber Juvenal Silva Farias; Paula Renata Lima Machado; Benedito Antônio Lopes da Fonseca
Journal:  ScientificWorldJournal       Date:  2013-01-31

2.  Chloroquine use improves dengue-related symptoms.

Authors:  Marcos Carvalho Borges; Luiza Antunes Castro; Benedito Antonio Lopes de Fonseca
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-08       Impact factor: 2.743

3.  The Viral Polymerase Inhibitor 7-Deaza-2'-C-Methyladenosine Is a Potent Inhibitor of In Vitro Zika Virus Replication and Delays Disease Progression in a Robust Mouse Infection Model.

Authors:  Joanna Zmurko; Rafael E Marques; Dominique Schols; Erik Verbeken; Suzanne J F Kaptein; Johan Neyts
Journal:  PLoS Negl Trop Dis       Date:  2016-05-10

4.  Release of dengue virus genome induced by a peptide inhibitor.

Authors:  Shee-Mei Lok; Joshua M Costin; Yancey M Hrobowski; Andrew R Hoffmann; Dawne K Rowe; Petra Kukkaro; Heather Holdaway; Paul Chipman; Krystal A Fontaine; Michael R Holbrook; Robert F Garry; Victor Kostyuchenko; William C Wimley; Sharon Isern; Michael G Rossmann; Scott F Michael
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240
  4 in total
  2 in total

Review 1.  Zika in the Americas, year 2: What have we learned? What gaps remain? A report from the Global Virus Network.

Authors:  Matthew T Aliota; Leda Bassit; Shelton S Bradrick; Bryan Cox; Mariano A Garcia-Blanco; Christina Gavegnano; Thomas C Friedrich; Thaddeus G Golos; Diane E Griffin; Andrew D Haddow; Esper G Kallas; Uriel Kitron; Marc Lecuit; Diogo M Magnani; Caroline Marrs; Natalia Mercer; Edward McSweegan; Lisa F P Ng; David H O'Connor; Jorge E Osorio; Guilherme S Ribeiro; Michael Ricciardi; Shannan L Rossi; George Saade; Raymond F Schinazi; Geraldine O Schott-Lerner; Chao Shan; Pei-Yong Shi; David I Watkins; Nikos Vasilakis; Scott C Weaver
Journal:  Antiviral Res       Date:  2017-06-06       Impact factor: 5.970

2.  An open source pharma roadmap.

Authors:  Manica Balasegaram; Peter Kolb; John McKew; Jaykumar Menon; Piero Olliaro; Tomasz Sablinski; Zakir Thomas; Matthew H Todd; Els Torreele; John Wilbanks
Journal:  PLoS Med       Date:  2017-04-18       Impact factor: 11.069
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.